본문 바로가기

기술동향

홈 > BT정보 > 기술동향

scrap print facebook twitter me2day
글 읽기

Keeping an eye on the Japanese genome

분류 기술동향 > 생명과학 > 유전체연구
출처 RIKEN RESEARCH 조회 3396
자료발간일 2012-01-13 등록일 2012-01-16
내용바로가기 http://www.riken.jp/en/research/rikenresearch/highlights/6808/
평점 평점이 없습니다.

 Keeping an eye on the Japanese genome

 

A particular type of age-related macular degeneration in the Japanese population is linked to four regions of the genome

 

 

Age-related macular degeneration (AMD) is a common disease that can result in blindness. It is caused by cell death in the eye’s retina, which is partly responsible for transforming visual stimuli into electrical signals to the brain. Asian populations tend to exhibit a particular type of the disease, called exudative AMD, which includes s in the blood vessels of the eye. Caucasians, however, tend to exhibit AMD without these vascular abnormalities. Now, a research team led by Michiaki Kubo at the RIKEN Center for Genomic Medicine in Yokohama has identified four genomic areas that increase the risk for exudative AMD in Japanese individuals1.

 

The researchers searched for genomic regions linked to exudative AMD by investigating single-nucleotide s in the human genome. They compared the frequencies of 500,000 single-nucleotide s between individuals with exudative AMD and normal, or control (Fig. 1), individuals. Other research groups had previously performed this kind of genome-wide association study (GWAS) in Caucasian populations, but not in the Japanese.

 

 

Figure 1: A photograph of a healthy eye. AMD-affected eyes have dark spots that lead to severe visual impairment in the elderly of developed countries.

 

Kubo and colleagues began by performing a GWAS on 800 Japanese individuals with exudative AMD and 3,000 Japanese controls; they identified two genomic regions previously linked to AMD in Caucasians. This suggested to the researchers that the mechanisms underlying AMD in both populations are likely to be similar.

 

In a ‘replication study’ using 700 patients and 15,000 controls, the researchers then carefully examined 77 additional genomic areas that showed potential as candidate exudative AMD-associated regions in their initial GWAS. The replication study yielded two additional genomic regions that were linked to exudative AMD. One of these-on chromosome 4-covered four nearby genes, so the researchers were unable to pinpoint with certainty which of the genes were responsible for the disease risk. However, another region-on chromosome 8-was linked to the gene called TNFRSF10A, which encodes a receptor expressed in the eye that modulates inflammation and cell death.

 

The variant of the gene that Kubo and colleagues linked to exudative AMD seemed to regulate the expression of the receptor. “We are next planning to investigate exactly how the signaling pathway initiated by this receptor would affect the development of exudative AMD,” explain Kubo and Satoshi Arakawa, the study’s first author.

 

The identification of these genomic regions that are linked to exudative AMD could aid in the development of new therapies. “Our results will also help in the construction of risk prediction models for exudative AMD,” say Kubo and Arakawa.

 

 

The corresponding author for this highlight is based at the Laboratory for Genotyping Development, RIKEN Center for Genomic Medicine

 
  1. Arakawa, S., Takahashi, A., Ashikawa, K., Hosono, N., Aoi, T., Yasuda, M., Oshima, Y., Yoshida, S., Enaida, H., Tsuchihashi, T., et al. Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nature Genetics 43, 1001–1004 (2011). article

 

 

 

관련기사
Phages found to use peptide to communicate with one another 2017-01-20
Seeking structure with metagenome sequences 2017-01-20
New Blood Test Can Predict Outcome for Ebola-Infected Patients 2017-01-20
'Molecular scissors' could point the way to genetic cures 2017-01-20
New Molecule Circumvents Antibiotic Resistance 2017-01-20
트럼프 효과에 기초소재·헬스케어 해외펀드 방긋 2017-01-20
“원격의료 인식 호전”… '헬스케어 미래관' 추가예산편성 2017-01-20
헬스케어 분야에서 빅데이터는 어떻게 활용되고 있는가 2017-01-20
SCM생명과학, 연구 중인 줄기세포치료제 ISO 9001 인증 획득 2017-01-20
“세포연구가 일으킬 대변혁…3가지 메가트렌드 왔다” 2017-01-20